Lv4
800 积分 2023-12-12 加入
Natural History and Outcomes of Cavernous Transformation of the Portal Vein in Cirrhosis
13小时前
待确认
High-dosage human albumin infusion may be superior for hypervolemic hyponatremia in cirrhosis with ascites
2天前
已完结
Glucagon-like peptide-1 receptor agonists for obesity: Growing popularity met with growing questions over safety
11天前
已完结
Cirrhotic portal vein thrombosis as a vascular rather than a thrombotic disorder
14天前
已关闭
Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis
15天前
已完结
Glutathione kinetics in normal man and in patients with liver cirrhosis
20天前
已完结
Defective Methionine Metabolism in Cirrhosis: Relation to Severity of Liver Disease
20天前
已完结
Dying for a cause: NETosis, mechanisms behind an antimicrobial cell death modality
20天前
已完结
Endothelial-to-mesenchymal transition: A targetable mechanism that contributes to portal vein thrombosis in cirrhosis
22天前
已完结
Treatment of portal vein thrombosis in cirrhosis is associated with no survival advantage: a retrospective controlled study
24天前
已完结
皖公网安备34019202002308
